However, the PTEN-deficient cancer cells mainly rely on the p110β isoform of class IA PI3K and its downstream effectors to transmit signals, which can trigger resistance against the PI3K p110α inhibitors by restoring the PI3K/AKT signaling pathway15–17. This evidence concerns the gene PTEN and cancer.